Clinical Fellow @ Heidelberg, Department of Radiation Oncology
Andreas Niethammer's Education
Ruprecht-Karls-Universität Heidelberg
Habilitation (Experimental Oncology)
Heidelberg, Dep. of Radiation Oncology
Board Certification Radiation Oncology (Habilitation in Experimental Oncology)
2003 - 2007
The Scripps Research Institute
Postdoctoral Fellow (Tumor Immunology)
2000 - 2003
Ruprecht-Karls-Universität Heidelberg
MD (Human Medizin)
1991 - 1997
Christian-Albrechts-Universität zu Kiel
Andreas Niethammer's Skills
Oncology
Clinical Research
Clinical Development
Pharmaceutical Industry
Drug Development
Lifesciences
Biotechnology
GCP
Infectious Diseases
Cancer
Andreas Niethammer's Summary
Andreas Niethammer, based in California, United States, is currently a Chief Medical Officer and Co-Founder at Aardvark Therapeutics, bringing experience from previous roles at Heidelberg University, Vaximm AG, Fate Therapeutics Inc and NantKwest. Andreas Niethammer holds a Habilitation in Experimental Oncology @ Ruprecht-Karls-Universität Heidelberg. With a robust skill set that includes Oncology, Clinical Research, Clinical Development, Pharmaceutical Industry, Drug Development and more, Andreas Niethammer contributes valuable insights to the industry. Andreas Niethammer has 4 emails on RocketReach.